Mercado global de sistemas de ultrassons cardiovasculares – Tendências do setor e previsão para 2031

Análise e tamanho do mercado do sistema de ultrassons cardiovasculares

De acordo com o relatório de 2022 da American Heart Association (AHA), aproximadamente 244,1 milhões de indivíduos em todo o mundo foram diagnosticados com doença cardíaca isquémica (DIC) em 2020, sendo que o Norte de África, o Médio Oriente, a Ásia Central e do Sul e a Europa de Leste apresentando as taxas de prevalência mais elevadas. Prevê-se que esta tendência se mantenha devido a fatores de risco generalizados, como a hipertensão , a obesidade, o tabagismo, a diabetes e os estilos de vida sedentários. Como resultado, espera-se que a procura de ultrassons no diagnóstico, monitorização e tratamento de doenças cardiovasculares aumente, impulsionando o crescimento do mercado de sistemas de ultrassons cardiovasculares durante todo o período de previsão. O mercado dos sistemas de ecografia cardiovascular desempenha um papel fundamental na cardiologia moderna, oferecendo capacidades essenciais de diagnóstico e ferramentas de monitorização para doenças cardiovasculares em todo o mundo.

O tamanho global do mercado de sistemas de ecografia cardiovascular foi avaliado em 1,84 mil milhões de dólares em 2023 e deverá atingir 2,80 mil milhões de dólares até 2031, com um CAGR de 5,37% durante o período de previsão de 2024 a 2031 . Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline , análise de preços e enquadramento regulamentar.

Âmbito do relatório e segmentação de mercado       

Market Definition

A cardiovascular ultrasound system is a medical device used for non-invasive imaging of the heart and surrounding blood vessels. It utilizes high-frequency sound waves (ultrasound) to create real-time images of the heart's anatomy, chambers, valves, and blood flow dynamics. This imaging technology helps healthcare professionals diagnose and monitor various cardiovascular conditions such as heart disease, heart valve disorders, congenital heart defects, and abnormalities in blood circulation.      

Cardiovascular Ultrasound System Market Dynamics

Drivers

• Growing Prevalence of Cardiovascular Diseases  

The increasing prevalence of cardiovascular diseases, encompassing conditions such as heart disease and hypertension, is a significant driver for the cardiovascular ultrasound system market. As these diseases continue to rise globally due to aging populations, sedentary lifestyles, and dietary habits, there is a heightened demand for early diagnosis and continuous monitoring. According to the June 2021 update from the World Health Organization (WHO), cardiovascular diseases (CVDs) remain the primary cause of global mortality, with approximately three-quarters of CVD-related deaths occurring in low- and middle-income countries. Cardiovascular ultrasound systems play a crucial role in this landscape by enabling healthcare providers to detect abnormalities in cardiac function, assess vascular health, and guide treatment decisions. This high mortality underscores an increasing demand for disease diagnostics and monitoring, which is poised to drive growth in the cardiovascular ultrasound system market.

• Technological Advancements in Ultrasound Imaging      

Innovations such as AI-driven algorithms for automated measurements and enhanced imaging quality are revolutionizing diagnostic capabilities. AI facilitates real-time image analysis, enabling faster and more accurate detection of cardiovascular conditions. These advancements not only streamline workflow and enhance diagnostic accuracy but also improve efficiency in clinical settings. For instance, in October 2020, GE Healthcare obtained 510k clearance from the United States Food and Drug Administration for its ultra-edition package of vivid cardiovascular ultrasound systems. This package incorporates new artificial intelligence (AI)-based features designed to enable clinicians to conduct faster and more consistent exams with improved repeatability. By integrating AI with ultrasound systems, healthcare providers can achieve higher diagnostic confidence, optimize treatment planning, and deliver personalized care tailored to individual patient needs, thus driving market growth and adoption.            

• Rising Adoption of Non-Invasive Diagnostic Techniques   

Non-invasive procedures reduce patient discomfort, minimize recovery times, and lower the risk of complications compared to traditional invasive methods. Cardiovascular ultrasound systems play a pivotal role in this shift by offering detailed insights into cardiac structure and function without the need for surgical intervention. This capability not only enhances patient satisfaction but also supports early detection of cardiovascular abnormalities, facilitates timely interventions, and improves overall healthcare outcomes. As healthcare systems prioritize patient safety and comfort, the demand for non-invasive cardiovascular ultrasound systems is expected to continue growing, driving market expansion.

Opportunities

• Development of Next-Generation Cardiovascular Ultrasound Systems   

Continued advancements in AI and machine learning technologies are opening new avenues for the development of next-generation cardiovascular ultrasound systems. AI-powered algorithms enable real-time image analysis, automated measurements, and decision support systems that enhance diagnostic accuracy and clinical workflow efficiency. These technologies hold promise for improving the detection of subtle cardiac abnormalities, predicting disease progression, and optimizing treatment strategies tailored to individual patient profiles. By harnessing the power of AI, manufacturers can innovate advanced ultrasound systems capable of delivering precise diagnostic insights, supporting personalized medicine approaches, and creating new opportunities for the market in cardiovascular care.           

• Personalized Medicine and Point-of-Care Testing     

The growing demand for personalized medicine and point-of-care testing solutions is driving the evolution of handheld and smartphone-integrated ultrasound devices within the cardiovascular ultrasound system market. These compact and portable devices offer flexibility in clinical settings, enabling healthcare providers to perform cardiac evaluations conveniently at the patient's bedside or in remote locations. They cater to the increasing need for rapid diagnostic assessments, early intervention, and personalized treatment plans tailored to individual patient needs. By integrating ultrasound technology with mobile platforms and cloud-based solutions, manufacturers are facilitating seamless data integration, real-time collaboration among healthcare teams, improved patient outcomes, and expanding market opportunities globally.

Restraints/Challenges

• High Cost of Ultrasound Equipment

The high initial cost and ongoing maintenance expenses associated with cardiovascular ultrasound systems pose significant barriers to market penetration, particularly in resource-constrained healthcare settings. The capital investment required for acquiring advanced ultrasound equipment, coupled with expenses for training healthcare staff and maintaining equipment functionality, can strain limited budgets. This financial burden often deters healthcare facilities from investing in new technologies or upgrading existing systems, thereby limiting access to advanced diagnostic capabilities and innovative treatment options for patients.        

• Challenges in Reimbursement Policies

Inconsistent reimbursement policies and varying reimbursement rates for cardiovascular ultrasound procedures across different regions and healthcare systems present challenges for market growth and adoption. Reimbursement complexities can affect healthcare providers' ability to recover costs associated with ultrasound services, impacting their willingness to invest in advanced equipment and integrate new technologies into clinical practice. Lack of uniformity in reimbursement guidelines and delays in reimbursement approvals further hinder market expansion efforts and innovation in cardiovascular ultrasound systems.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, Siemens Healthineers introduced advanced AI applications for its Acuson Sequoia ultrasound system, alongside a new 4D transesophageal (TEE) transducer designed for cardiology examinations. Among the new AI-driven cardiology features are AI Measure, which automates the acquisition of essential measurements for routine echocardiography exams, and 2D HeartAI, enhancing efficiency and workflow for cardiac strain imaging procedures         
• In February 2024, Royal Philips announced the integration of artificial intelligence into its cardiac ultrasound devices and broader cardiac care offerings aimed at enhancing clinical confidence and operational efficiency. The Philips Ultrasound Compact System 5500 CV, a portable solution, now incorporates an AI-driven automation tool known as automated strain quantification. This tool aids in evaluating the left ventricle's function, a critical metric for assessing heart health
• In August 2023, Siemens Healthineers unveiled the Acuson Origin, a specialized cardiovascular ultrasound system featuring advanced artificial intelligence capabilities, during the annual meeting of the European Society of Cardiology (ESC)

Cardiovascular Ultrasound System Market Scope

The market is segmented on the basis of test type, technology, device display, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Transthoracic Echocardiogram
• Transoesophageal Echocardiogram
• Stress Echocardiogram
• Other Echocardiograms

Technology

• 2D Ultrasound
• 3D and 4D Ultrasound
• Doppler Imaging

Device Display

• Colour Display
• Black and White (B/W) Display

End-User

• Hospital and Cardiology Centres
• Home and Ambulatory Care Settings
• Research Institutes
• Medical Device, and Pharmaceutical Companies
• Other End Users

Cardiovascular Ultrasound System Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, test type, technology, device display, and end-user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to expanding preventive healthcare practices and the widespread adoption of advanced technologies. The region's robust healthcare infrastructure further accelerates market growth.                

Espera-se que a Ásia-Pacífico testemunhe um crescimento significativo durante o período de previsão devido ao aumento da prevalência de doenças crónicas. Espera-se também que as políticas de reembolso e os quadros regulamentares favoráveis ​​reforcem a expansão do mercado nesta área durante o período de previsão. 

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do cenário competitivo e da quota de mercado do sistema de ultrassons cardiovasculares

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• GE Healthcare (EUA)
• Koninklijke Philips NV (Holanda)
• FUJIFILM Holdings Corporation (Japão)
• Siemens Healthineers AG (Alemanha)
• Hitachi Medical Corporation (Japão)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Samsung Electronics Co. (Coreia do Sul)
• Canon Medical Systems (Japão)
• Chison Medical Imaging Co. (China)
• Esaote SPA (Itália)
• Kalamed GmbH Medical Systems (EUA)
• (EUA)

SKU-12915